surmount-1 tirzepatide obesity nejm 2022 weight loss percent vs Semaglutide for Loss: Which Drug Delivers Better Results? In patients with #obesity, incretin-based
Description
Tirzepatide: first approval
Tirzepatide therapy starts at 2.5 mg and escalates to 5 mg, 7.5 mg, 10 mg, 12.5 mg, and sometimes 15 mg depending on response and tolerance
Some medications may cost $2 per dose, while others can cost over $400
In November 2023, Zepbounds manufacturer, Eli Lilly, noted that FDA approval was based on results from the phase 3 SURMOUNT-1 and SURMOUNT-2 clinical trials
